Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
August 31, 2003
Study Completion Date
September 30, 2004
Conditions
Breast Cancer
Interventions
DRUG
amonafide dihydrochloride
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
lead
Memorial Sloan Kettering Cancer Center
OTHER
collaborator
National Cancer Institute (NCI)
NIH
NCT00074100 - Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy | Biotech Hunter | Biotech Hunter